February 2023: The Clinical Study on the Analgesic Activity of PAX-1 in Patients with Persistent Cancer Pain was approved by the DNM and CNEIS in El Salvador. July 2021: Sodium meta-arsenite received orphan-drug designation from the US FDA for the "treatment of patients with...
20 February 2020: Phase II clinical trial for Brain metastases in non-small cell lung cancer (NSCLC) approved by the Taiwan Food and Drug Administration (TFDA) 27 February 2020: Komipharm files for emergency clinical trial of its investigative drug to treat coronavirus pneumonia, which is...
16 August 2019: Phase II clinical trial for glioblastoma (GBM) approved by the NSW Human Research Ethics Committee (HREC) in Australia 19 December 2019: Phase I clinical trial on solid tumours approved by USA FDA ...
Komipharm completed all engineering drawings for the project to refurbish the factory at 11 Monterey Rd, Dandenong South, VIC. Manufacturing equipment were procured, completed and shipped to an Australian secured depot/warehouse. Tendering process was completed and sent out into the market to receive expression...